Valsts: Izraēla
Valoda: angļu
Klimata pārmaiņas: Ministry of Health
VANCOMYCIN AS HYDROCHLORIDE
NEOPHARM (ISRAEL) 1996 LTD
J01XA01
POWDER FOR CONCENTRATED SOLUTION
VANCOMYCIN AS HYDROCHLORIDE 1000 MG
I.V, ORAL
Required
XELLIA PHARMACEUTICALS APS, DENMARK
VANCOMYCIN
Intravenous infusion:Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci.It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs.Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted.Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections.Antibiotic therapy is as an adjunct to appropriate surgical measures wh
2016-11-02
10 20 30 40 50 60 70 80 90 100 Creatinine clearance (ml/min) Creatinine clearance (ml/s) 0.50 1. 00 1.50 1545 1380 1235 1080 925 770 620 465 320 155 Daily close of vancomycin (mg) Izlasiet visu dokumentu